“…In the past decade, the biological interest of 1,5-benzodiazepines have been extended to curing several diseases such as cancer, viral infections, and cardiovascular disorders. , Depending on the substitution pattern and nature of substituents, benzodiazepines can have a wide range of half-lives. Moreover, 1,5-benzodiazepines are key synthons for the synthesis of various fused ring systems such as triazolo-, oxadiazolo-, oxazino-, or furano-benzodiazepines. − Over the past several years, considerable studies have been reported for the synthesis of 1,5-benzodiazepines utilizing ytterbium triflate, gallium(III)triflate, erbium(III)triflate, scandium(III)triflate, ytterbium perfluorooctanesulfonate, BF 3 -etherate, p -toulenesulfonic acid, NaBH 4 , MgO/POCl 3 , polyphosphoric acid, CeCl 3 -NaI/SiO 2 , Al 2 O 3 /P 2 O 5 , sulfated zirconia, 1,3- n -dibutylimidazolium bromide, SbCl 3 -Al 2 O 3 , iodine, magnesium perchlorate, sodium dodecyl sulfate, Ag 3 PW 12 O 40 , zinc chloride, dodecyl sulfonic acid, piperidine acetic acid, La(NO 3 ) 3 , SmI 2 , sulfamic acid, organic acid, HClO 4 -silica, YbCl 3 , ceric ammonium nitrate, N -bromosuccinimide, acetic acid/MW, (NH 4 )H 2 PW 12 O 40 , SnCl 2 , K10-montmorillonite, Zn-montmorillonite heterogeneous catalysts borax/phosphorus oxychloride, amberlyst-15, InBr 3 , InCl 3 , NbCl 5 , and RuCl 3 · x H 2 O as catalysts. In addition, a solvent-free procedure has been reported for the synthesis of 1,5-benzodiazepines using iodine, silver nitrate, and HBF 4 -SiO 2 as catalysts at room temperature.…”